Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

Neurophet gains FDA 510(k) clearance for Neurophet AQUA, advancing multiple sclerosis analysis with AI-driven precision

software for electric and magnetic brain stimulation "Neurophet tES/TMS LAB". Neurophet has set its top priority to helping patients suffering from brain diseases. Based on expertise in neuroscience, Neurophet will continue to challenge and grow to...

Automated red blood cell exchange boosts quality of life for sickle cell patients

Antoinette Gawin, President and CEO of Terumo BCT. "Exchange therapies remain a mainstay to avoid disease complications, helping these warriors live their lives. We continue partnering with patient advocacy and policy groups to expand access to...

Preclinical study shows NUZ-001 reduces TDP-43 aggregation in ALS

offices, and staff throughout Europe and North America. Ncardia is built on the belief that stem cell technology will help bring better therapies to patients faster. The company's goal is to enable biopharmaceutical companies in drug discovery to...

Bracco Diagnostics Inc. reaches one million injections milestone with its MRI agent, VUEWAY® (gadopiclenol)

has reached over one million patient injections at over 480 customer sites. This hallmark achievement is significant as it helped address the unmet medical need to minimize gadolinium (Gd) exposure per MRI procedure without compromising image...

GoodRx debuts a new e-commerce platform, starting with Opill®

leverage our platform’s reach to expand market presence, increase consumer access to essential medications and ultimately help drive growth." The GoodRx and Opill partnership addresses significant gaps in healthcare access, particularly for the...

Great Bay Bio launches its Intelligent Drug Development Ecosystem

to culture media development and optimization, etc., giving revolutionary changes to biopharmaceutical development, helping customers develop products faster and better. Mr. Kingsley Leung, co-founder and chairman of GBB, said: "I am very happy to...

ARTHEx Biotech doses first patient in Phase I-IIa ArthemiR™ trial for Myotonic Dystrophy Type 1

like ATX-01 may be critical for patients, families and the broader community to gain additional knowledge which may help lead to better clinical outcomes and possibly an approved treatment. I am excited to evaluate ATX-01's dual mechanism of action...

The U.S. FDA provides positive guidance on the Phase III trial of 64Cu-SAR-bisPSMA for recurrent prostate cancer.

data that we have seen in our trials with 64Cu-SAR-bisPSMA to date. We believe that better diagnostic tools will help clinicians determine the best course of treatment for their patients, and our team and collaborators look forward to bringing this...

BioCare collaborates with AeroSafe Global to introduce sustainable cold chain solutions

"Our cold chain service program provides the most advanced thermal packaging solutions while reducing waste and emissions, helping create a more sustainable future." About AeroSafe Global: AeroSafe Global is a leader in biopharmaceutical cold chain...

LenioBio partners with ReciBioPharm to scale up ALiCE® technology and accelerate vaccine production

in both process development and contract manufacturing, ReciBioPharm offers the knowledge and resources necessary to help customers develop and manufacture promising new therapies to meet the needs of patients across the world.

Drug Discovery 2024

drug discovery research or translating your promising therapy to the clinic, you’ll be sure to discover something that can help you at this year’s event.

ISCT becomes the first cell and gene therapy organization to achieve ANAB accreditation for its workforce development program

learners acquire skills that are transferable, standardized, and respected across the global CGT industry. This not only helps the sector address critical skills gaps but also supports individuals on their professional development journeys." The...

FDA approves Bristol Myers Squibb's COBENFY™, a novel treatment for adult schizophrenia.

treatment that works for them. Having a variety of treatment options gives patients and healthcare providers the tools to help manage this serious condition,” said Gordon Lavigne, chief executive officer of the Schizophrenia & Psychosis Action...

nuBioAge, nuHx, and Marius Pharmaceuticals launch a collaborative GLP-1 comparison study in male patients.

and pharmacology solutions. With specific pharmacy clinicians trained in counseling each patient population, they aim to help patients find the right medicine for their health condition while working alongside research partners to develop expertly...

Merz Aesthetics launches Ultherapy PRIME, the next generation of nonsurgical skin lifting treatments

long history of empowering health care professionals, patients and employees to live every day with confidence. We aim to help people around the world look, feel and live like the best versions of themselves — however they define it. Clinically...

Restore Hyper Wellness has partnered with MECOTEC to enhance their offerings in cryotherapy solutions.

natural performance. Restore's nationwide presence of 225+ studios continues to grow rapidly, fueled by its commitment to helping people feel their best. About MECOTEC: MECOTEC has grown from a pioneer in cryo-technology (the first cryo-chamber was...

The American Kidney Fund's Rare Kidney Disease Advocacy Day on Capitol Hill aims to gather support for legislation to boost awareness and treatment of rare kidney diseases.

Genetic counselors are trained and certified to interpret complex genetic information, and they play a critical role in helping identify why people get chronic kidney disease (CKD). Currently, Medicare does not recognize genetic counselors as...

ChromaDex expands its pharmaceutical-grade Niagen® IV and injection offerings to more leading wellness clinics.

or NR). Clinically proven to increase NAD+ levels, Niagen is the most efficient and superior-quality NAD+ booster helping people transform the way they age.

City of Hope and BRC treat first patient with BRC-001 in a breast cancer care trial.

of breast surgery and lead investigator of the trial. "We hope this work will yield innovative, FDA-approved therapies to help patients complete their lifesaving treatments." The clinical trial entitled "High Cannabidiol (CBD) Standardized Extract...

Bloomage 2024 Mid-Year Report: International raw material sales exceed domestic Chinese market sales for the first time

and strategic partnerships, aligned with global health trends and diverse customer needs. This approach has successfully helped the segment reach a 45.60% increase in revenue year-over-year. Expanding International Presence and Customer-Centric...